The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma

The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma

Background and purposeMicrowave ablation (MWA) is one of the first-line therapy recommended for early-stage hepatocellular carcinoma (HCC). However, the residual tumor, resulting from insufficient ablation, led to recurrence and metastasis of liver cancer. Novel combination strategies are urgently n...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenhui Wang, Fuyuan Wu, Zhe Wu, Mengfan Zhang, Qiang Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
XIAP
anti-tumor immunity
hepatocellular carcinoma
microwave ablation
residual tumor
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1482954/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items